Essilor plans acquisitions in Latin America for 2015
Essilor planea adquisiciones en Latinoamérica para 2015
Intel ID : 220189
| Synopsis |
|
Essilor, a pharmaceutical company, plans to invest EUR 1.000m in acquisitions, throughout 2015, in China, India and Latin America. The objective of this investment is to increase its presence in emerging markets.
(content in spanish)
Essilor, compañía francesa dedicada al negocio farmacéutico, tiene previsto desembolsar EUR 1.000m en adquisiciones durante 2015 en China, India y Latinoamérica. El objetivo de esta inversión es incrementar su penetración en mercados emergentes. |
|
||||
| Intel ID | 220189 | |
| Value | EUR 1.000,00m | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Essilor
(31 Dec 2013) |
Revenue: EUR 5.065,00m | |
| Date |
 |
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.02.02 Eyewear 30 Healthcare / 30.02 Healthcare Equipment & Supplies |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.